175 related articles for article (PubMed ID: 24738485)
21. Alginate coated chitosan nanoparticles are an effective subcutaneous adjuvant for hepatitis B surface antigen.
Borges O; Silva M; de Sousa A; Borchard G; Junginger HE; Cordeiro-da-Silva A
Int Immunopharmacol; 2008 Dec; 8(13-14):1773-80. PubMed ID: 18801462
[TBL] [Abstract][Full Text] [Related]
22. Cationic PLA nanoparticles for DNA delivery: comparison of three surface polycations for DNA binding, protection and transfection properties.
Munier S; Messai I; Delair T; Verrier B; Ataman-Onal Y
Colloids Surf B Biointerfaces; 2005 Jul; 43(3-4):163-73. PubMed ID: 15941652
[TBL] [Abstract][Full Text] [Related]
23. Humoral and cell-mediated immune responses elicited by poly (DL-lactide) adjuvanted filarial antigen molecules.
Saini V; Verma AK; Kushwaha V; Joseph SK; Murthy PK; Kohli D
Drug Deliv; 2014 May; 21(3):233-41. PubMed ID: 24171405
[TBL] [Abstract][Full Text] [Related]
24. Immune response by nasal delivery of hepatitis B surface antigen and codelivery of a CpG ODN in alginate coated chitosan nanoparticles.
Borges O; Cordeiro-da-Silva A; Tavares J; Santarém N; de Sousa A; Borchard G; Junginger HE
Eur J Pharm Biopharm; 2008 Jun; 69(2):405-16. PubMed ID: 18364251
[TBL] [Abstract][Full Text] [Related]
25. APC targeted micelle for enhanced intradermal delivery of hepatitis B DNA vaccine.
Layek B; Lipp L; Singh J
J Control Release; 2015 Jun; 207():143-53. PubMed ID: 25886704
[TBL] [Abstract][Full Text] [Related]
26. Development characterizations and evaluation of Poly(-ε-caprolactone)-based microspheres for hepatitis B surface antigen delivery.
Tomar P; Karwasara VS; Dixit VK
Pharm Dev Technol; 2011 Oct; 16(5):489-96. PubMed ID: 20550463
[TBL] [Abstract][Full Text] [Related]
27. Comparison of PLA microparticles and alum as adjuvants for H5N1 influenza split vaccine: adjuvanticity evaluation and preliminary action mode analysis.
Zhang W; Wang L; Liu Y; Chen X; Li J; Yang T; An W; Ma X; Pan R; Ma G
Pharm Res; 2014 Apr; 31(4):1015-31. PubMed ID: 24170280
[TBL] [Abstract][Full Text] [Related]
28. Biodegradable poly-l-lactide based microparticles as controlled release delivery system for filarial vaccine candidate antigens.
Anugraha G; Madhumathi J; Jeya Prita PJ; Kaliraj P
Eur J Pharmacol; 2015 Jan; 747():174-80. PubMed ID: 25514604
[TBL] [Abstract][Full Text] [Related]
29. Cationic polymers that enhance the performance of HbsAg DNA in vivo.
Bos GW; Kanellos T; Crommelin DJ; Hennink WE; Howard CR
Vaccine; 2004 Dec; 23(4):460-9. PubMed ID: 15530694
[TBL] [Abstract][Full Text] [Related]
30. Immunopotentiation of hepatitis B vaccine using biodegradable polymers as an adjuvant.
Sivakumar SM; Sukumaran N; Nirmala L; Swarnalakshmi R; Anilbabu B; Siva L; Anbu J; Shanmugarajan TS; Ravichandran V
J Microbiol Immunol Infect; 2010 Aug; 43(4):265-70. PubMed ID: 20688285
[TBL] [Abstract][Full Text] [Related]
31. Augmented humoral and cellular immune responses to hepatitis B DNA vaccine adsorbed onto cationic microparticles.
He X; Jiang L; Wang F; Xiao Z; Li J; Liu LS; Li D; Ren D; Jin X; Li K; He Y; Shi K; Guo Y; Zhang Y; Sun S
J Control Release; 2005 Oct; 107(2):357-72. PubMed ID: 16099068
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of cationic nanoparticles of biodegradable copolymers as siRNA delivery system for hepatitis B treatment.
Wang J; Feng SS; Wang S; Chen ZY
Int J Pharm; 2010 Nov; 400(1-2):194-200. PubMed ID: 20801205
[TBL] [Abstract][Full Text] [Related]
33. Polyethylenimine-coated PLGA nanoparticles-encapsulated Angelica sinensis polysaccharide as an adjuvant to enhance immune responses.
Gu P; Wusiman A; Wang S; Zhang Y; Liu Z; Hu Y; Liu J; Wang D
Carbohydr Polym; 2019 Nov; 223():115128. PubMed ID: 31427012
[TBL] [Abstract][Full Text] [Related]
34. Cationic transfersomes based topical genetic vaccine against hepatitis B.
Mahor S; Rawat A; Dubey PK; Gupta PN; Khatri K; Goyal AK; Vyas SP
Int J Pharm; 2007 Aug; 340(1-2):13-9. PubMed ID: 17446015
[TBL] [Abstract][Full Text] [Related]
35. The promotion of type 1 T helper cell responses to cationic polymers in vivo via toll-like receptor-4 mediated IL-12 secretion.
Chen H; Li P; Yin Y; Cai X; Huang Z; Chen J; Dong L; Zhang J
Biomaterials; 2010 Nov; 31(32):8172-80. PubMed ID: 20692033
[TBL] [Abstract][Full Text] [Related]
36. Potentiating humoral and cellular immunity using a novel hybrid polymer-lipid nanoparticle adjuvant for HBsAg-VLP vaccine.
Liu X; Min Q; Song H; Yue A; Li Q; Zhou Q; Han W
J Nanobiotechnology; 2023 Nov; 21(1):441. PubMed ID: 37993870
[TBL] [Abstract][Full Text] [Related]
37. Synthesis, characterization and evaluation of novel triblock copolymer based nanoparticles for vaccine delivery against hepatitis B.
Jain AK; Goyal AK; Gupta PN; Khatri K; Mishra N; Mehta A; Mangal S; Vyas SP
J Control Release; 2009 Jun; 136(2):161-9. PubMed ID: 19239919
[TBL] [Abstract][Full Text] [Related]
38. Interactions of antigen-loaded polylactide particles with macrophages and their correlation with the immune response.
Kanchan V; Panda AK
Biomaterials; 2007 Dec; 28(35):5344-57. PubMed ID: 17825905
[TBL] [Abstract][Full Text] [Related]
39. Poly(D,L-lactic-co-glycolic acid) microsphere delivery of adenovirus for vaccination.
Wang D; Molavi O; Lutsiak ME; Elamanchili P; Kwon GS; Samuel J
J Pharm Pharm Sci; 2007; 10(2):217-30. PubMed ID: 17706180
[TBL] [Abstract][Full Text] [Related]
40. Biodegradable microspheres alone do not stimulate murine macrophages in vitro, but prolong antigen presentation by macrophages in vitro and stimulate a solid immune response in mice.
Luzardo-Alvarez A; Blarer N; Peter K; Romero JF; Reymond C; Corradin G; Gander B
J Control Release; 2005 Dec; 109(1-3):62-76. PubMed ID: 16269200
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
